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Calcium oxalate nephrolithiasis, a free or fixed particle disease. The
chances of stone formation occurring through a free particle mechanism
were calculated using the approach of Finlayson and Reid [1]. For these
calculations we used new data on nephron dimensions, supersaturation
and ciystal growth rates in urine, and also incorporated the size increasing
effect of ciystal agglomeration. The calculations were performed assuming
different levels of oxalate excretion, simulating the diurnal variation and
acute hyperoxaluria following a dietary load. In addition urinary flow
conditions were varied according to changes in daily urinary volume. It is
shown that during the normal transit time of urine through the nephron,
particles can obtain a size big enough to be retained in the nephron. This
is mainly due to the size-increasing effect of the agglomeration process.
The precipitable amount of oxalate present is not limiting for the
maximum attainable particle size. However, acute increases in oxalate
excretion do pose a risk because supersaturation is reached earlier in the
nephron and consequently the crystal particles are allowed more time to
increase in size. In conclusion, the present calculations demonstrate that
during the normal transit time through the kidney, crystalline particles can
be formed which are large enough to be retained because of their size and
thus form the nidus of a stone. The highest risk is encountered at the end
of those collecting ducts where crystals formed in nephrons with a long
loop of Henle meet and agglomerate.
Supersaturation of the urine with respect to calcium oxalate is
a prerequisite for calcium oxalate urinary stone formation.
Urinary stones, however, do not form only because the urine is
supersaturated. The occurrence of supersaturated urine and
crystalluria is a common phenomenon for both stone-forming
patients and healthy subjects [2—41. This finding led to the notion
that the precipitation of calcium oxalate monohydrate (COM) by
itself poses no problem as long as the particles formed are allowed
to pass freely through the urinary tract. Problems occur only when
the particles are retained and allowed to form the nidus of a stone.
Retention is defined here as movement through the urinary tract
at a speed lower than that of the urinary flow. Theoretically
retention can occur because the particles become too big to pass
freely through the renal tubules, by adhesion to the tubular cells
or by trapping of particles at sites of disturbed urinary flow. When
the size of a particle is the decisive factor, the process is defined
as the free particle mechanism. This is in contrast to the fixed
particle mechanism, where adhesion plays a dominant role.
Finlayson and Reid [1] calculated the chances of forming a stone
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through a free particle mechanism in the renal tubules, pelvis and
the bladder. The calculations were based on average normal
values for oxalate excretion, kidney structure and nephron dimen-
sions. They found that even under the worst possible assumptions,
when all oxalate is allowed to precipitate and crystal growth
occurs at maximum speed, the crystalline particles could never
become large enough to be retained by sheer size in the nephron
or the pelvis during normal transit times through the kidney. Only
bladder stone formation might be explained by this mechanism.
This led to the conclusion that particle retention caused by
adherence to cells or disturbed urinary flow conditions must play
an important role in stone formation. The validity of these
calculations still stands; however, several refinements can be
made. New data have become available on the dimensions of the
renal tubules through which the particles must pass. There is a
significant variation in the thickness of the epithelial cells lining
the renal tubules along the length of the nephron [5]. Conse-
quently, the inner diameter of the nephron varies considerably
from one section of the nephron to the next. In addition, the
length of the nephrons may vary greatly, (compare short loops vs.
long loops.) Also, urinary flow is not constant throughout the
nephron, but varies for each segment, depending on the size and
number of nephrons and the amount of water resorbed up to that
point. Precipitation of all oxalate from the urine is unlikely to
occur. Precipitation will continue only until equilibrium concen-
trations have been reached. Crystal growth in urine will not
proceed at maximum rate but at a reduced rate. Urinary oxalate
excretion shows a wide diurnal variation [6,71. Especially after
ingestion of oxalate rich foods it may be sharply increased [8].
Instead of using only an average daily excretion of oxalate it may
thus be more relevant to base the calculations on the extremes
encountered during the day. Finally, particle size will be greatly
influenced by the occurrence of crystal agglomeration, a process
which was not considered in the original calculations. A contrib-
utory role for crystal agglomeration in retention is apparent in in
vivo studies of calcium oxalate nephrolithiasis. When nephrolithi-
asis was induced by induction of acute hyperoxaluria, the type of
particles retained in the renal tubules changed with time [9]. At
early time periods both single crystals as well as small agglomer-
ates were seen in the renal tubules. However, only large agglom-
erates of calcium oxalate monohydrate crystals were still present
three days after the hyperoxaluric challenge indicating the
importance of agglomeration in crystal retention. We have now
repeated these calculations using the more accurate up-to-date
data and also incorporated the size increasing effects of crystal
agglomeration.
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Methods
Data used
The data used in the original and present calculations are
summarized in Table 1. Validation of (the choice of) data is given
below.
Supersaturation and growth rate. Since oxalate is the limiting
factor in the precipitation of calcium oxalate from urine, the
calculations are based on the pool of oxalate available. In the
original calculations all oxalate was allowed to precipitate and
the growth rate was taken to be maximal. Some oxalate, however,
will remain in solution. In an average normal urine containing
0.44 mmoles oxalate, 4 mmoles calcium and having a relative
supersaturation of 5, approximately 0.1 mmoles of oxalate will
remain in solution at equilibrium, thus 0.34 mmoles or 77.5% will
precipitate out maximally. A further refinement is to correct for
the diurnal variation in oxalate excretion. With normal daily
excretion rates of oxalate, the highest concentration during the
day is twice or more the mean daily concentration [6,7], and after
ingestion of oxalate rich food the concentration can go up 289%
[8]. We therefore based the calculations on three different sce-
narios of daily oxalate excretion, low normal (0.03 1 mM), high
normal (0.62 mM) and acute high (0.89 mM) oxalate, with constant
calcium excretion. The solubility of calcium oxalate monohydrate
in the urine of stone-formers, that is, the amount present at
equilibrium, is not different from that in the urine of healthy
subjects [10]. Thus, in the three scenarios, the precipitable amount
of oxalate is respectively 0.24 m, 0.54 m and 0.82 m. We did
not take into consideration that stone formers tend to excrete
more calcium, this would increase the precipitable amount of
oxalate. As will be shown further, this parameter is not the
limiting factor in the determination of the particle size. The
maximal COM linear crystal growth rate, as used in the original
calculations, is 2 X i0 cm per minute. In urine COM. crystal
growth is reduced by more than 50% [10]. For the calculations we
used a 50% inhibited growth rate, i.iO cm per minute.
Transit times. We know the amount of fluid entering the
kidneys, 125 ml of serum filtered per minute giving 116 ml of
filtrate or 58 mllmin per kidney. In the proximal tubule 65% of the
water is reabsorbed. At the end of the proximal tubule thus 35%
remains, on average throughout the proximal tubule 67.5%
remains. For the descending loop of Henle these numbers are
25%, 10% and 17.5%. Under high diuresis, daily urine volume
16.7 liters, no further resorption is assumed to occur. When the
urine is concentrated further, to 1.44 or to 0.6 liters, this occurs in
the inner and outer medullary collecting ducts, the degree de-
pending upon the final urinary output. Thus the flow in ml per
minute can be calculated for each segment of the nephron (Table
1). Since the internal diameter and the number of the segments
are known [11], the flow in mm per second can be calculated as flow
(ml per min)/area segment number of segments. For the proximal
tubule, for instance, flow equals 39.1 mI/mm, area is 7.1, iO mm2
and number is 1.2 million. The flow in mm/second thus is 0.76. The
total length of the proximal tubule is on average 18 mm, thus
the transit time is 24 seconds. These numbers compare well to the
actual transit time measured in stop-flow studies in dogs under
maximum diuresis of 28 seconds [12] and the flow velocity
measured in rats using video-fluorescence, 0.48 mm/sec [13]. In
Table 1 the transit times of urine through the different segments
is given for different situations. These are differences in the length
of the descending loop of Henle (short 0 mm, medium 7 mm and
long 14 mm), and ascending loop of Henle (short 6 mm, medium
12 mm, long 18 mm) and differences in daily urinary volume (16.7
liters, 1.44 liters and 0.6 liters, respectively). The high volume
mimics the situation immediately following ingestion of a large
volume of water; 1.44 liters represents the average urinary volume
and 0.6 liters the minimum. Under a normal oxalate loading
condition the nucleation threshold is surpassed somewhere in the
descending loop of Henle due to water resorption [14]. We
therefore base our calculations under normal conditions on
nucleation starting at the end of the descending loop of Henle,
allowing for nucleation lag time in the descending loop of Henle.
The passage time for the crystals thus will be the time needed to
pass the ascending loop of Henle, distal tubule, outer medullaiy
collecting duct (OMCD), inner medullary collecting duct (IMCD)
and duct of Bellini (DOB) (Table 1).
Under acute hyperoxaluria, crystals can already be found in the
proximal tubule (Fig. 1) [9, 15, 16]. For this condition, therefore,
nucleation can be assumed to start in the proximal tubule. Crystals
then have a passage time equal to that for the whole kidney.
Crystal numbers. In the original calculations, the number of
particles which can be expected per transit time per collecting
duct during crystalluria was taken to be 33.75. This number, which
now appears to be too low, was derived as follows. From the data
of [2] during crystalluria one can expect approximately 7200
crystals per ml of urine. Assuming a flow rate of 1440 ml per day,
or 1 ml per minute, this means 7200 crystals per minute. On
average there are 320 ducts of Bellini per kidney and the transit
time of particles through the kidney was taken to be three minutes.
Thus you may expect 7200 x 3/640—33.75 crystals per duct per
transit time. The number 7200 was extracted from the particle size
distribution measurements during crystalluria performed by Rob-
ertson, and reflected the number of particles in the peak of their
measured distribution rate. The actual crystal density, however,
will be the sum of the crystal numbers of all particle sizes counted.
In [2] at least 50% of the crystals were not detected because they
were outside the detection limits. Taking this all in consideration,
the actual number of crystals one can expect during crystalluria is
24084 crystals per ml, which translates to 73 to 154 crystals per
duct per transit time, depending on the transit time. Moreover
crystals are not uniformly distributed throughout the renal tu-
bules. Even under severe hyperoxaluric conditions, the crystals are
concentrated in only a few of the renal tubules (Fig. 2). To mimic
this effect the calculations were also performed assuming crystals
to be present in 50% of the ducts only. Overall three crystalluria
scenarios are used, 33.75, 73 to 154 and 146 to 308 crystals per
collecting duct.
Tubular dimensions. Originally [1] the restrictive diameter was
taken to be 200 pm, which is the outer diameter of the duct of
Bellini at the papillary tip. But the actual dimensions that particles
encounter are much smaller. First, the opening at the papillary tip
is not round but slit-like, as is clearly seen in Figure 3. In this
picture the long axis varies from 60 to 120 tm and the small axis
from 7 to 23 m. Second, the inner diameter of the renal tubules
which determines the sticking size of a particle is much smaller
than the outer diameter. Due to variations in the epithelial
thickness, 0.1 to 120 jim, the inner diameter varies greatly along
the nephron. The data for human kidneys [11] are not complete
enough for our purposes, and therefore we used data for rabbit
kidneys [5] which compare reasonably well to human kidneys
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Table 1. Data used for calculations
Segment P DIH AIH D OMCD IMCD DOB
Tubular dimensions
Outer D, H z 50—65 14—22 14—22 20—50 50—200 50—200 200
Outer D, R p. 45—65 15—40 20—30 20—60 40—55 55—300 300
Epithelial thickness, R p. 10—15 0.5—1.5 0.3—1.0 0.7—18 5—10 10—120 100—120
Inner D, R p. 25—35 14—37 19—29 18—30 30—35 35—60 60—100
Area 1O4mm2 7.1 5.1 4.5 4.5 8.29 17.7 50.2
Length, H mm 12—24 0—14 6—18 2—9 16 6 5
Number per kidney 1,200,000 1,200,000 1,200,000 1,200,000 200,000 5,120 320
Segment DIH AlH' D OMCDd IMCD" DOB
Flow characteristics
Resorp/' % 65 25 0 0 0/6.8/7.2 0/2.3/2.5 0/0/0
Remain. % 67.5 22.5 10 10 10/6.6/6.4 10/2.0/1.6 10/0.9/0.3
Flow mI/mm 39.1 13.1 5.8 5.8 5.8/3.8/3.7 5.8/1.0/0.9 5.8/0.5/0.2
Flow n/d 10 p.1/s 5.4 1.8 0.8 0.8 4.8/3.2/3.1 189/32/29 3021/259/103
Flow n/d mm/s 0.76 0.35 0.18 0.18 0.6/0.4/0.4 10.7/1.8/1.6 60/5.2/2
T, s. LOH sec 24 0 33 31 28/41/42 1/3/4 0.1/1/2.5
T, m. LOH sec 24 20 67 31 28/41/42 1/3/4 0.1/1/2.5
T, 1. LOH sec 24 40 100 31 28/41/42 1/3/4 0.1/1/2.5
Load Total T F&R
K&K
normal peak acute
Oxalate concentration mM 0.31 0.31 0.62 0.89
Precipitable oxalate mM
Crystal growth rate cm min'
0.31
2 x iO
0.24
1 X iO
0.54
1 X iO 0.821 X iO
Crystals per minute 7200 7200,24084 7200,24084 7200,24084
Crystals/duct/T
s. loops 117/133/137 73/83/86 73/83/86 73/83/86
m. loops 171/187/191 11.25 107/117/120 107/117/120 107/117/120
1. loops 224/241/245 141/152/154 141/152/154 141/152/154
Data on human kidneys (H) are derived from [11], those on rabbit kidneys (R) from [5]. Abbreviations are: P, proximal; DLH, descending loop of
Henle; ALH, ascending ioop of Henle; D, distal; OMCD, outer medullary collecting duct; IMCD, inner medullary collecting duct; DOB, duct of Bellini;
F&R, [1]; K&K, [this article].
Transit times are calculated for short (s), medium (m) and long (1) loops of Henle.
a Three different situations are given, based on a daily urinary volume of 16.7, 1.44 or 0.6 liters, respectively.bWater resorption over total length of segment, for the calculation of the average % water remaining it is assumed that resorption is uniform over
total length.
Plasma filtered is 125 mI/mm, filtrate is 116 mI/mm or 58 mml/min per kidney.
dWith maximal flow there is no resorption after the loop of Henle, under other situations additional resorption occurs in OMCD and IMCD.
The calculations are also performed with double these numbers, simulating the situation that only 50% of the collecting ducts contain crystals.
(Table 1). In the rabbit the inner diameter approximates 25 to
35 p.m in the proximal tubule, 14 to 37 p.m in the loop of Henle,
19 to 29 p.m in the distal tubule, 30 to 35 p.m in the outer
medullary collecting duct, 35 to 60 p.m in the inner medullary
collecting duct, and 60 to 100 p.m for the duct of Bellini.
Agglomeration. Crystal agglomeration can have a considerable
increasing effect on the particle size, which originally was disre-
garded. The effect of crystal agglomeration is accounted for in two
manners. First, assuming the particles agglomerate ideally, this
will yield agglomerates with a density identical to that of the
constituting particles: p = 2.2 g cm3. They will have a diameter
of (n)113 D, with D the diameter of the single particles. Second,
with the more realistic situation where the particles do not
agglomerate ideally and the agglomerates have inclusions of
solute and organic material [17], resulting in a lower density, it is
here assumed to be 1.5 g cm3. The diameter of the agglomer-
ates formed is then (n)113 (PcomlPagg.)113 D.
Experimental urolithiasis. Crystal deposits in the rat kidney were
induced as previously described by either the administration
sodium oxalate [18] or ethylene glycol [19]. The kidneys were fixed
by perfusion and studied by light microscopy and scanning
electron microscopy.
Calculations
Single crystal scenario. In the worst case scenario, when all the
oxalate is precipitated into one single particle, the maximum
single particle size reached (D) can be calculated using formula
(1). T is the transit time for the particle from the site where
nucleation starts to the papillary tip. Under normal oxalate
loading conditions, nucleation starts in the ascending loop of
Henle and T varies from 93 to 180 seconds, depending on the
length of the nephron and daily urinary volume. With acute high
oxalate loading nucleation may already start in the proximal
tubule and T varies from 117 to 244 seconds. If A is the amount
of oxalate excreted in the urine in mmoles per day, B is the
number of ducts of Bellini per papilla and C is the number of
papilla per kidney, then the amount of oxalate present per
collecting duct is A T/B C 90 1440 (90 being the molecular
weight of oxalate and 1440 being the number of minutes per day).
— -- n
'I'. ' -' a-1.
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Fig. 1. An aggregate of calcium oxalate
monohydrate ciystals present in the proximal
tubule of the kidney of a male Sprague-Dawley
rat, observed six hours after intraperitoneal
administration of 7 mg sodium oxalate/100 g rat
body weight (X7,000).
Further, the density of whewellite, p, is 2.2 g/cm3. The size of the
particle formed, D, is:
D=2.(1.62ATI90.14O2(4/3)pB'C)' (1)
If A = 0.44 mmoles, T = 3.4mm., B = 40 and C = 8, then D5 =
59.4 m. The ratio of molecular weights of whewellite and oxalate
is 1.62. The numerator is divided by 2 because A is the output of
two kidneys. However, as was discussed above, not all oxalate will
precipitate out and the amount of oxalate present may vary under
different conditions, When you correct for these factors, the
maximum attainable size will be 54.6 m, 72 .tm and 103 m
under respectively the low normal, high normal and acute high
scenario. In this worst case scenario, with all material going into
one single crystal, the sizes reached would thus be large enough
for the particles to be retained in the collecting ducts. In reality,
however, the material will not be concentrated into one single
crystal, but rather be divided over several crystals.
Multi-crystal scenario, no agglomeration. When the total amount
of oxalate is distributed over n crystals, the size of the individual
particles will maximally be D (n)t13. The number n changes
depending on the crystalluria scenario and the transit time (Table
1). If all particles are growing at the same rate, the maximum
single particle size under the three crystalluria scenarios would be
respectively 16.9, 10.2 to 13.1 and 8.1 to 10.4 m (low normal
oxalate), 22.3, 13.5 to 17.3 and 10.7 to 13.7 tm (high normal),
31.9, 19.2 to 24.7 and 15.3 to 19.6 jtm (high acute). Still, these
single crystal sizes are not realistic because of the restriction on
the particle size posed by the velocity of the crystal growth process
itself. In the normal scenario, where nucleation is assumed to
occur at the end of the descending loop of Henle, the particle has
maximally 180 seconds to grow. A particle growing at the maxi- Fig. 2. Histological section of a rat kidney after two weeks of consumption of
mum uninhibited rate of 2 X 104cm per mm can thus reach 6 0.75% ethylene glycol and 2% ammonium chloride. Calcium oxalate crystals
m. At 50% inhibited rate this will be 3 j.tm. Under acute oxalate are restricted to onlya few renal tubules (x110).
ftTht'4 h?i±tJ,1 p4
r
I,
I
7
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Fig. 3. Renal papillary tip of a normal male
Sprague-Dawley rat, illustrating slit-like openings
of the ducts of Bellini which are 7 to 23 pm wide
and 60 to 120 pm long (X210).
loading one might expect nucleation to start in the proximal
tubule and the maximum attainable size for a single particle will
be 4.1 m at the papillary tip with 50% growth inhibition. Thus,
when the particles remain single, the maximum size reached will
be much smaller than the inner diameter of the duct of Bellini.
Multi-crystal scenario, agglomeration occurring. The picture be-
comes different when the particles formed are allowed to agglom-
erate. If we assume the crystals to grow in a cubic form of 3 m
(normal oxalate load, long loops, volume 0.6 liter) and then
agglomerate ideally, the particles formed would be 18.4 or
23.2 m (50% scenario) large (Table 2). The packing in the
agglomerate, however, will not be ideal. Synthetic agglomerates
show much lower densities than 2.2 due to the inclusion of solute
[20]. Crystalline material in the tubules is invariably associated
with organic material and/or cell debris [21]. If we assume an
agglomerate density of 1,5 (compared to 2.2 for pure whewellite
and 1 for synthetic agglomerates) the particles formed reach
sizes of 20.9 and 26.4 m, respectively. Under acute oxalate
loading, where the single particles form in the proximal tubule and
have more time to grow, the maximum size of the agglomerates
will be 25 and 31.5 m, respectively. The specific values fot the
different scenarios are given in Table 2.
Discussion
When Finlayson and Reid published their calculation data
some 20 years ago, it provided very convincing evidence that
kidney stones cannot start through a free particle mechanism, but
that somewhere particle retention due to adhesion or disturbed
urine flow must occur. Thus the crystallization of COM in urine
from stone formers would not be expected to behave different
from that in urine of healthy subjects. With respect to supersat-
uration, nucleation and crystal growth, the available data support
this conclusion. Though COM supersaturation of stone former
urine may on average be higher [21—23] and crystalluria occurs
more often [2—4, 24, 25] they are not exclusive for stone formers.
Also, crystal growth inhibition in stone former urine, on average,
may be significantly lower [10], but the range overlaps completely
with that found for non-stone forming subjects. Overall the
differences in the occurrence of urinary supersaturation, crystal-
luria or the rate of crystal growth are not sufficient to explain the
occurrence of stone formation [23]. Urine from stone formers can
only be clearly distinguished from those of healthy subjects in
their effects on crystal agglomeration. Though crystalluria is
common in both stone formers and healthy subjects, the stone
formers tend to excrete more large particles, especially agglom-
erates [25]. When precipitation is induced in urine, stone former
urine produces more agglomerates [26]. The inhibition of crystal
agglomeration is significantly reduced in stone former urine [10,
27], with a large percentage of the stone former population
showing values below the lower limit of normal [10]. Furthermore,
the reduction in agglomeration inhibition is directly related to the
severity of the disease [10]. Finally, some of the high molecular
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Table 2. Maximum particle sizes during passage through nephron
Segment P DLH ALH D OMCD IMCD DOB
Normal oxalate load
Inner D. t 25—35 14—37 19—29 28—30 30—35 35—60 60—100
Precip no no no yes yes yes yes
G.t.a
s sec 0 0 33 64 92/105/106 93/108/110 93/109/113
m sec 0 0 67 98 126/139/140 127/142/144 127/143/147
I sec 0 0 100 131 159/172/173 160/175/177 160/176/180
D, single
s 0 0 0.6 1.1 1.5/1.8/1.8 1.5/1.8/1.8 1.6/1.8/1.9
m s 0 0 1.1 1.6 2.1/2.3/2.3 2.1/2.4/2.4 2.1/2.4/2.5
1 g 0 0 1.7 2.2 2.7/2.9/2.9 2.7/2.9/2.9 2.7/2.9/3.0
D,aggL"
s ,x 0 0 0.6 1.1 1.5/1.8/1.8 2.6/3.3/3.3 6.5/7.9/8.3
m 1.1 1.6 2.1/2.3/2.3 4/5.8/5.9 10/11.6/12.1
1 .t 1.7 2.2 2.7/2.9/2.9 5.5/6.2/6.3 13.9/15.6/16.1
D, 5Q%C
sx 0 0 0 0 2.9 8 20.3
Acute oxalate load
Inner D. g 25—35 14—37 19—29 28—30 30—35 35—60 60—100
Precip. yes yes yes yes yes yes yes
G. timea
s sec 24 24 57 88 116/129/130 117/132/134 117/133/137
m 24 44 111 142 170/180/184 171/186/188 171/187/191
I 24 64 164 195 223/236/237 224/239/241 224/240/244
D,single
0.4 0.4 1 1.5 1.9/2.2/2.2 2/2.2/2.2 2/2.2/2.3
m 0.4 0.7 1.9 2.4 2.8/3/3.1 2.9/3.1/3.1 2.9/3.1/3.2
I ji 0.4 1.1 2.7 3.3 3.8/3.9/4 3.7/4/4 3.8/4/4.1
D,aggP
s 0.4 0.4 1 1.5 1.9/2.2/2.2 3.4/4.0/4.0 8.4/9.6/10.2
m 0.4 0.7 1.9 2.4 2.8/3/3.1 5.5/6.2/6.2 13.8/15.2/15.8
I g 0.4 1.1 2.7 3.3 3.8/3.9/4 7.7/8.6/8.6 19.8/21.3/22
D, 50%°
lgs 0 0 0 0 4 10.9 27.7
Abbreviations are in Table 1.
a Three different situations are given, based on daily urine volumes of 16.7, 1.44 or 0.6 liters, respectively.
b When the crystals are evenly distributed over the nephrons, the first agglomerates are expected in the inner medullary collecting ducts.
Assuming that only 50% of the ducts contain crystals, only calculated for the long loops, low volume scenario.
weight compounds from stone formers have a diminished inhibi-
tory effect on crystal agglomeration [28, 291. If stone formation is
caused by a fixed particle mechanism solely, how can these data be
explained? This apparent discrepancy prompted us to review the
original calculations and now incorporate the size increasing
effects of crystal agglomeration. From our results it is clear that
this size-increasing effect has serious implications. When we
assume even distribution of the particles formed over the collect-
ing ducts, the particle sizes which can be reached through
nucleation, growth and agglomeration combined, fall within the
size range of the tubule itself. This makes retention of particles
through sheer size a feasible mechanism. The maximum attain-
able particle size becomes even bigger when we consider that
during crystalluria not all ducts contain crystals (Table 2). Finlay-
son and Reid pointed out that these calculations are sensitive to
small changes in the transit time. This becomes obvious when we
compare the sizes obtained in nephrons with short loops of Henle
to those obtained in nephrons with long loops of Henle. Further,
it seems likely that solid particles will not flow with the same rate
as the urine-fluid but at a slower rate. Each time a particle hits the
tubular walls, its velocity will be reduced, The extent of this will
depend on how strong the interaction is between the particle and
the cell-membrane. In this respect it is interesting to note that,
using red blood cells, COM crystals were found to interact much
stronger with the membrane than calcium oxalate dihydrate
crystals [30]. It remains to be established whether this effect is also
seen with kidney cells and whether in this respect single crystals
and agglomerates behave differently. The chance that particles
will be retained by adhering to epithelium will be especially higher
whenever a bend in the tubule is encountered or when two tubular
flows combine. The highest risk for forming large agglomerates
will be at the end of the collecting ducts and in the duct of Bellini
where single particle sizes are biggest and crystal concentration is
highest. From plastic casts made of post-mortem human kidneys,
it appears that distal tubules and collecting ducts show acute
angles (70°) and z-bends [31]. These aberrations are more prom-
inent at the bases of the papillae in the lower calices. An intriguing
aspect was that these acute angles and bends were located at the
same site where so-called "laminated seed-stones" were concen-
trated. These were stones with the usual lamination of crystalline
and organic material and one or two crystalline centers.
Overall, under the realistic assumptions made here, a normal
oxalate excretion of 0.44 mmoles per day, 50% inhibited crystal
growth and a relative supersaturation of 5, the particles formed,
especially agglomerates, have a fair chance of being retained
through their size. This can actually be seen when calcium oxalate
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Fig. 4. Opening of a duct of Bellini at the renal
papillary tip of a male Sprague-Dawley rat.
Opening is occluded by aggregates of calcium
oxalate nionohydrate crystals observed 6 hours
after the intraperitoneal administration of 7 mg
sodium oxalate/100 g rat body weight (X 1,800>.
nephrolithiasis is experimentally induced in rats. Large agglom-
erates are found blocking the nephron at the papillary tip (Fig. 4).
When acute hyperoxaluria is induced in rats by intraperitoneal
injection of sodium oxalate or dietary administration of 1%
ethylene glycol, nephrolithiasis ensues [9, 13, 32] and agglomer-
ates are even found in the proximal tubule (Fig. 1) [9]. The
structure of the stones found in the renal pelvis under these
conditions suggested that tubular deposits agglomerated to form
the nidus of the stone [32]. The danger of acute hyperoxaluria, for
example after a dietary load, may thus be that the nucleation
threshold is surpassed earlier in the nephron and the particles
have more time to increase in size and form the nidus of a stone.
It is thus possible that particles form through nucleation, growth
and agglomeration which are big enough to be retained in the
collecting duct. When such a large agglomerate is retained, it will
further accrue organic and inorganic material and become a
stone. The whole concretion may be pushed along the nephron or
if it is too big to move further, increase in size until it breaks into
the pelvic area. When the particle is pushed along, it may damage
the cells lining the tubule and reach the basement membrane to
become attached there [is]. This could explain the reported
frequent occurrence of tubular remnants inside urinary stones
[33].
In conclusion, the calculations presented here support the
theory that formation and subsequent retention of large particles
because of aberrance in calcium oxalate crystallization processes,
especially crystal agglomeration, may be the crucial first steps
leading to stone formation. The model described can be used to
evaluate the effects of changes in nephron morphology.
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